Aurobindo rallies 5 per cent following stellar Q3 results

Posted By:
Subscribe to GoodReturns

Aurobindo rallies 5 per cent following stellar Q3 results
Aurobindo Pharma: Quotes, News
BSE 711.40BSE Quote18.65 (2.62%)
NSE 711.60NSE Quote19.4 (2.73%)
Shares in Aurobindo Pharma jumped 5 per cent in trade after the company reported a good set of results for Q3 2013.
The stock was last trading at Rs 518.10, following a four fold jump in net profit. Aurobindo Pharma reported a net profit of Rs 417 crores, which was a new record for the company.

Revenues grew 81 per cent to Rs 2140, led by strong growth in the US markets.

Aurobindo Pharma is the market leader in Semi-Synthetic Penicillins and has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

GoodReturns.in

Read more about: aurobindo pharma
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'